PCSK9 and atherosclerosis: To the best of our knowledge, only one other group [17] reported that active vaccination against PCSK9 could reduce atherosclerosis development in APOE*3Leiden.CETP mice; however, we showed the atheroprotective effect of L-IFPTA+ in a different murine model of severe atherosclerosis.